JP2023542209A5 - - Google Patents
Info
- Publication number
- JP2023542209A5 JP2023542209A5 JP2023518383A JP2023518383A JP2023542209A5 JP 2023542209 A5 JP2023542209 A5 JP 2023542209A5 JP 2023518383 A JP2023518383 A JP 2023518383A JP 2023518383 A JP2023518383 A JP 2023518383A JP 2023542209 A5 JP2023542209 A5 JP 2023542209A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antibody
- antibody fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20197975.4 | 2020-09-24 | ||
| EP20197975 | 2020-09-24 | ||
| PCT/EP2021/076052 WO2022063819A1 (en) | 2020-09-24 | 2021-09-22 | Novel human antibodies binding to human cd3 epsilon |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023542209A JP2023542209A (ja) | 2023-10-05 |
| JP2023542209A5 true JP2023542209A5 (https=) | 2024-09-24 |
| JP7851303B2 JP7851303B2 (ja) | 2026-04-24 |
Family
ID=72644112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023518383A Active JP7851303B2 (ja) | 2020-09-24 | 2021-09-22 | ヒトｃｄ３イプシロンに結合する新規なヒト抗体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230357398A1 (https=) |
| EP (1) | EP4217391A1 (https=) |
| JP (1) | JP7851303B2 (https=) |
| KR (1) | KR20230074192A (https=) |
| CN (1) | CN116209680A (https=) |
| AU (1) | AU2021350342A1 (https=) |
| CA (1) | CA3189473A1 (https=) |
| IL (1) | IL301276A (https=) |
| WO (1) | WO2022063819A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3227537A1 (en) | 2021-07-27 | 2023-02-02 | Morphosys Ag | Combinations of antigen binding molecules |
| JP2026502768A (ja) * | 2022-10-25 | 2026-01-27 | アブレクシス， エルエルシー | 抗ｃｄ３抗体 |
| WO2025003511A1 (en) | 2023-06-30 | 2025-01-02 | Morphosys Ag | Dual-targeting of flt3 and cd123 co-expressing tumor cells by functional complementation of cycat® halfbody molecules |
| WO2025036892A1 (en) | 2023-08-14 | 2025-02-20 | Morphosys Ag | Cycat halfbody molecules comprising sterically occluding moieties |
| WO2025082777A1 (en) | 2023-10-17 | 2025-04-24 | Morphosys Ag | Dual-targeting of muc16 and mesothelin co-expressing tumor cells by functional complementation of cycat® halfbody molecules |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| EP1958962A3 (en) | 1997-06-12 | 2013-05-01 | Novartis International Pharmaceutical Ltd. | Artificial antibody polypeptides |
| US6136599A (en) | 1998-12-10 | 2000-10-24 | Bayer Corporation | Human hybrid host cell for mammalian gene expression |
| ES2327382T3 (es) | 1999-07-20 | 2009-10-29 | Morphosys Ag | Metodos para presentar (poli)peptidos/proteinas en particulas de bacteriofagos a traves de enlaces disulfuro. |
| RS53008B2 (sr) | 2007-04-03 | 2022-12-30 | Amgen Res Munich Gmbh | Interspecijski specifičan cd3-epsilon vezujući domen |
| US8367586B2 (en) | 2010-11-19 | 2013-02-05 | Morphosys Ag | Collection and methods for its use |
| CA2861003C (en) | 2012-01-13 | 2023-03-28 | Julius-Maximilians-Universitat Wurzburg | Dual antigen-induced bipartite functional complementation |
| CN106459201A (zh) * | 2014-05-28 | 2017-02-22 | 豪夫迈·罗氏有限公司 | 结合人和食蟹猴CD3ε的抗体 |
| WO2019034580A1 (en) | 2017-08-14 | 2019-02-21 | Morphosys Ag | HUMANIZED ANTIBODIES FOR CD3 |
| WO2020115115A1 (en) | 2018-12-05 | 2020-06-11 | Morphosys Ag | Multispecific antigen-binding molecules |
-
2021
- 2021-09-22 US US18/246,052 patent/US20230357398A1/en active Pending
- 2021-09-22 JP JP2023518383A patent/JP7851303B2/ja active Active
- 2021-09-22 KR KR1020237013083A patent/KR20230074192A/ko active Pending
- 2021-09-22 WO PCT/EP2021/076052 patent/WO2022063819A1/en not_active Ceased
- 2021-09-22 CA CA3189473A patent/CA3189473A1/en active Pending
- 2021-09-22 EP EP21782518.1A patent/EP4217391A1/en active Pending
- 2021-09-22 CN CN202180065049.3A patent/CN116209680A/zh active Pending
- 2021-09-22 IL IL301276A patent/IL301276A/en unknown
- 2021-09-22 AU AU2021350342A patent/AU2021350342A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023542209A5 (https=) | ||
| US20230287119A1 (en) | Anti-cd3 antibody and molecules comprising the antibody | |
| CN111484555B (zh) | 新型双特异性cd3/cd20多肽复合物 | |
| EP3668898A1 (en) | Humanized antibodies for cd3 | |
| RU2020130795A (ru) | Нейтрализующие антитела к env вич-1 и их применение | |
| JP2022533538A5 (https=) | ||
| JP7851303B2 (ja) | ヒトｃｄ３イプシロンに結合する新規なヒト抗体 | |
| JP2020515277A5 (https=) | ||
| JP7830445B2 (ja) | インターロイキン１アルファに特異的な真のヒト抗体 | |
| JP2024540148A5 (https=) | ||
| JP2023510982A5 (https=) | ||
| JP2021512652A5 (https=) | ||
| JP2022553908A5 (https=) | ||
| JP2024516098A5 (https=) | ||
| WO2023186081A1 (zh) | 抗tigit-抗pvrig双特异性抗体、其药物组合物及用途 | |
| EP4225367A1 (en) | TRUE HUMAN ANTIBODY SPECIFIC FOR INTERLEUKIN 1 ALPHA (IL-1alpha) | |
| JP2023545007A (ja) | インターロイキン１アルファに特異的な真のヒト抗体 | |
| JP2023545005A (ja) | インターロイキン１アルファに特異的な真のヒト抗体 | |
| WO2023186063A1 (zh) | 抗pvrig抗体、其药物组合物及用途 | |
| CN118922448A (zh) | Cd3特异性的去免疫抗体 | |
| JP2024522075A5 (https=) | ||
| JP2024546763A5 (https=) | ||
| JP2024519078A5 (https=) | ||
| IL277899B2 (en) | Methods and preparations for treating yellow fever | |
| JP2024516621A5 (https=) |